British regulators issued the alert for two versions of a jab given to millions of pensioners and pregnant women after ...

Guillain-Barre syndrome is a rare but serious condition which needs urgent treatment in hospital to prevent it progressing.

The medicines regulator has issued a warning to NHS health staff about a small increased risk of a rare condition affecting ...

OVER 20 people developed a potentially paralysing illness after getting the respiratory syncytial virus (RSV) vaccine. The UK ...

European Commission President Ursula von der Leyen faces a rare no-confidence vote in the European Parliament this week.

A Romanian politician has claimed a no-confidence motion challenging Ursula von der Leyen signals the beginning of the end of ...

The UK drug watchdog has issued an alert to the NHS after the RSV jab was linked to a rare condition that needs "urgent ...

The partnership will give Chugai access to Gero’s artificial intelligence technology to discover novel targets in ...

J&J is looking to add a hormone-sensitive indication to its prostate cancer therapy, which was originally approved in 2023.

After several PD-1xVEGF competitors forged alliances with Big Pharma players, Summit Therapeutics, the frontrunner in this hot cancer drug field, is reportedly seeking its own deal. | After several PD ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Despite representing only 4% of the world’s population, the United States accounts for over half of science Nobel Prizes ...